STAT

AUGUST 2, 2024

Where and when the Covid-19 pandemic began — in Wuhan, China in late 2019 — is well known. How it began is a matter of heated controversy. There are two competing hypotheses, one of which is hindering the process of scientific discovery and could hold back the development of vaccines and other antiviral agents in the U.S. The zoonosis hypothesis proposes that SARS-CoV-2, the virus that causes Covid-19, was naturally transmitted from an animal to one or more humans in a so-called we

Vaccines 364

Vaccines 364

PharmaVoice

AUGUST 2, 2024

As AI tools move from hype to a daily reality at pharma companies, here are the insights users are gaining.

278

278

STAT

AUGUST 2, 2024

In the face of ongoing shortages of the obesity and diabetes medications known as GLP-1s, patients have resorted to a wide array of sources for the drugs, including medical spas and telehealth sites that prescribe compounded versions of the drugs. But a new paper published in JAMA Network Open highlights one of the riskiest sources of non-branded drugs: illegal online pharmacies that bypass prescription entirely.

Online Pharmacies 359

Online Pharmacies Compounding Labelling Diabetes 359

BioPharma Dive

AUGUST 2, 2024

Adaptimmune’s Tecelra is the first TCR cell therapy to reach market and, at $727,000, is also the priciest cellular medicine for cancer in the U.S.

123

123

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

STAT

AUGUST 2, 2024

Contract disputes between hospitals and health plans have become routine, but they tend to be local , affecting a handful of hospitals and the people in the surrounding communities. This latest one is different. It involves the country’s biggest private health insurer, UnitedHealthcare, and its biggest hospital chain, HCA Healthcare. If they can’t strike a deal on prices by Sept. 1, 38 hospitals and their affiliated physician groups and surgery centers across four states — T

Hospitals 363

Hospitals 363

pharmaphorum

AUGUST 2, 2024

Discover how digital transformation is reshaping the pharmaceutical industry and learn how to prepare your workforce for the future with this guide on building a future-ready digital workforce in pharma.

107

107

Pharma Times

AUGUST 2, 2024

Cancer is estimated to affect more than three million people living in the UK, according to Macmillan Cancer Support

123

123

STAT

AUGUST 2, 2024

Some of the world’s finest athletes were sidelined by a torn anterior cruciate ligament (the ligament that helps stabilize the knee joint) long before the torch was lit for the Paris Olympics. The list of women competitors with ACL tears is stunning. Basketball player Cameron Brink , rugby medalist Shiray Kaka, gymnast Asia D’Amato, and several other athletes will not be competing because of this all-too-common, season-ending, and potentially career-ruining injury.

335

335

pharmaphorum

AUGUST 2, 2024

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on cardiovascular outcomes with the drug.

113

113

STAT

AUGUST 2, 2024

LONDON — U.S. regulators have authorized a cutting-edge treatment relying on T cells for a rare cancer that arises in the body’s soft tissues, extending the power of immunotherapies to difficult-to-reach sarcomas.   The medicine, called Tecelra and developed by Adaptimmune Therapeutics, is what’s known as a T cell receptor therapy.

319

319

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Express Pharma

AUGUST 2, 2024

ENTOD Pharmaceuticals has appointed Prof Vivek Padgaonkar, former Director of the OPPI (Project & Policy), as a non-executive independent director. Prof Padgaonkar brings prior experience from his extensive work with various lobbying and think-tank organisations on healthcare issues. His collaborations with several government ministries have significantly shaped current pharmaceutical policies.

Research Laboratories 98

Research Laboratories Pharmaceutical Companies Pharmaceutical Companies 98

STAT

AUGUST 2, 2024

The promise of scientific and medical innovation often comes with a downside: improvements in care benefit some people, but not all. Without concerted effort, that is exactly what could happen with liquid biopsy — an evolving technology aimed at improving cancer care using just a few milliliters of blood or other body fluids. Liquid biopsy technologies are maturing at a rapid pace.

311

311

European Pharmaceutical Review

AUGUST 2, 2024

For the first time in over a decade, there is a new treatment option for patients with synovial sarcoma, a rare soft tissue cancer. The US Food and Drug Administration (FDA) has granted accelerated approval for the cell therapy TECELRA ® (afamitresgene autoleucel) to treat adults with unresectable or metastatic forms of the disease. Adaptimmune Therapeutics highlighted that TECELRA is a melanoma-associated antigen A4 (MAGE-A4)-directed genetically modified autologous T cell immunotherapy.

Chemotherapy 98

Chemotherapy Immunization Immunity 98

STAT

AUGUST 2, 2024

A special committee of the board of directors of 23andMe rejected an offer from the company’s co-founder and CEO, Anne Wojcicki, to take the company private. In a letter made public Friday, the board said that Wojcicki’s proposal failed to offer a premium to 23andMe’s current stock price, did not have committed financing from other investors, and came with other conditions it rejected.

315

315

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Commerce

AUGUST 2, 2024

In deal that has the potential to reach $1.1 billion, Otsuka aims to grow its drug pipeline, specifically in the field of rare and autoimmune diseases.

105

105

STAT

AUGUST 2, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning and happy Friday. We discuss a new innovative immunotherapy, and we take a look at some of the earnings highlights yesterday.

Drug Pricing 307

Drug Pricing Drug Development 307

Express Pharma

AUGUST 2, 2024

Parexel, one of the world’s reportedly largest clinical research organisations (CROs) providing the full range of Phase I to IV clinical development services, announced the release of its 2023 Environmental, Social and Governance (“ESG”) Report. The ESG Report is part of Parexel’s annual commitment to disclose and communicate the progress of its sustainability priorities, underscoring the company’s core values of putting Patients First and delivering With Heart. “Our ESG p

Communication 102

Communication 102

STAT

AUGUST 2, 2024

Good morning, and happy Friday. This is Jonathan Wosen, West Coast biotech and life sciences reporter, filling in for Ed Silverman while he’s away from the Pharmalot campus. As you may know from my past entries, I’m no coffee drinker, but here are some newsy items to help wake you up and kick-start your weekend. … The FDA has approved a cutting-edge treatment for a rare soft tissue cancer, STAT tells us.

Compounding 253

Compounding Immunity Immunization 253

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Pharmacist

AUGUST 2, 2024

The Royal Pharmaceutical Society (RPS) has expressed concern over the potential criminalisation of pharmacists who supply puberty blockers, following a High Court ruling earlier this week upholding an emergency prohibition order on the medicines. The legislation – brought in by former health secretary Victoria Atkins in May – makes it a criminal offence to supply […] The post RPS concern over 'potential criminalisation' in supplying puberty blockers appeared first on The Pharmaci

91

91

Express Pharma

AUGUST 2, 2024

Now that the Union Budget 2024-25 has been analysed, feted and criticised, it is time to remember that budgetary allocations are only a signal of the government’s intentions. The actions that follow and their implementation are more crucial. Given that we have around seven months before the next budget, it’s fair to say that most postbudget criticism could be aimed at setting the stage for February 2025’s Union Budget 2025-26.

Adverse Reactions 100

Adverse Reactions Documentation Labelling 100

pharmaphorum

AUGUST 2, 2024

Explore the latest mergers, acquisitions, and partnerships in June 2024 involving LucidHealth, Syncona, Spur Therapeutics and more. Stay updated on the business collaborations shaping the industry.

104

104

Pharma Times

AUGUST 2, 2024

The third leading cause of cancer mortality accounts for over 700,000 deaths every year

116

116

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

AUGUST 2, 2024

FDA clears GSK's Jemperli as first-line therapy for all endometrial cancer patients, seen as key to driving sales above the $1bn threshold

98

98

Outsourcing Pharma

AUGUST 2, 2024

Rejuvenate Biomed and SAS have announced a creative partnership aimed at making big changes to drug discovery through the development of a user-friendly, AI-powered tool.

Drug Development 79

Drug Development 79

The Pharmacist

AUGUST 2, 2024

The Royal Pharmaceutical Society (RPS) has expressed concern over the potential criminalisation of pharmacists who prescribe puberty blockers, following a High Court ruling earlier this week upholding an emergency prohibition order on the medicines. The legislation – brought in by former health secretary Victoria Atkins in May – makes it a criminal offence to supply […] The post RPS concern over 'potential criminalisation' in prescribing puberty blockers appeared first on The Pha

77

77

Pharmaceutical Technology

AUGUST 2, 2024

AbbVie has completed its acquisition of all outstanding shares of Cerevel Therapeutics in a deal valued at $8.7bn.

98

98

pharmaphorum

AUGUST 2, 2024

FDA has approved Adaptimmune's Tecelra for synovial sarcoma, the first engineered T-cell therapy for solid tumours

103

103

Outsourcing Pharma

AUGUST 2, 2024

As the BioSecure Act approaches its 2032 implementation, Contract Development and Manufacturing Organizations (CDMOs) must prepare for significant industry shifts.

79

79

pharmaphorum

AUGUST 2, 2024

Discover how artificial intelligence is revolutionising the pharmaceutical industry and how it can potentially save time, resources, and lives. Learn more about the impact of AI on pharma and discussions at PING 2024.

96

96

Pharmafile

AUGUST 2, 2024

Abbvie has announced the acquisition of Cerevel Therapeutics, strengthening its neuroscience pipeline. Cerevel has multiple programmes across neurological and psychiatric conditions such as schizophrenia, Parkinson’s disease and mood disorders. One example is emraclidine, a next-generation antipsychotic positive allosteric modulator (PAM) of the muscarinic M4 receptor, indicated for the treatment of schizophrenia.

72

72

BioPharma Dive

AUGUST 2, 2024

The one-time drug developer is pivoting to cancer research. Elsewhere, Neurocrine reported a strong quarter and venBio raised half a billion dollars for biotech investing.

Drug Development 70

Drug Development 70

Express Pharma

AUGUST 2, 2024

What edge does generative AI have over traditional methods? Before the pharmaceutical industry started warming up to generative AI, most operations and processes were conducted with minimal AI involvement. Even in cases where AI was incorporated, the algorithms were slow and inefficient, leading to increased ( 1 ) costs and operational complexities.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Vaccines Compounding 69